India's VC funding recovery 'anaemic' compared to global surge

India's venture capital market is experiencing a recovery that significantly lags behind the robust global resurgence witnessed in early 2026. While global VC deal value surged 161% in the first seven months of 2026, India's comparable metric advanced merely 5% year-on-year, a disparity that underscores structural challenges in the domestic ecosystem. This divergence is particularly notable given that India has historically positioned itself as a major VC hub within Asia-Pacific; however, current performance suggests the market faces headwinds that are not affecting developed venture ecosystems globally.

The scale differential between India's contribution to global capital deployment and its deal volume reveals an acute concentration problem. India accounted for just 1% of global VC funding by value while representing 7% of global deal volume—a ratio indicating that Indian deals are substantially smaller in average size than their global counterparts. This compositional difference suggests that while Indian startups are accessing capital, they are not attracting the mega-round commitments that characterize the current global cycle. Capital raised by VC and growth equity funds in India did double year-over-year to approximately $5.4 billion, demonstrating some momentum, but this figure remains constrained relative to the global context.

Within the Indian market, recovery has been highly concentrated rather than broad-based. Deal value in the $100+ million segment surged 86% quarter-over-quarter in Q2 2026, indicating that mega-deals are driving the available capital deployment. Fintech emerged as an exceptional performer, with funding surging 2.3x quarter-over-quarter in Q2 2026, suggesting that investor capital is gravitating toward specific high-conviction verticals rather than distributing evenly across the technology ecosystem. This sectoral imbalance implies that large portions of India's startup economy remain under-capitalized relative to prior cycles, with early-stage and mid-market companies experiencing substantially tighter capital availability.

The characterization of India's recovery as "anaemic" relative to global conditions reflects investor confidence gaps and potentially higher risk premiums applied to Indian ventures outside flagship sectors. While India's position as a secondary VC destination in Asia-Pacific remains intact, the magnitude of underperformance relative to global trends—particularly in an environment of widespread capital redeployment—suggests structural issues beyond cyclical weakness, including sector concentration, deal sizing dynamics, and competitive disadvantages in attracting international capital flows.